Human MIA3/ARNT/D320 ORF/cDNA clone-Adenovirus plasmid (NM_001300867)

Cat. No.: pGMAD000114
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Human MIA3/ARNT/D320 adenoviral expression plasmid for MIA3 adenovirus packaging, MIA3 adenovirus.

Our GM-Adenovirus vector is optimized with the GMVC-modified Adeasy adenovirus packaging system. Find more about the GMVC-modified adenovirus packaging system.

pdf Datasheet
pdf MSDS
pdf Terms of Use
Target products collection

Go to MIA3/ARNT products collection>>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

Purchase
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMAD000114
Gene Name MIA3
Accession Number NM_001300867
Gene ID 375056
Species Human
Product Type Adenovirus plasmid (overexpression)
Insert Length 2358 bp
Gene Alias ARNT,D320,TANGO,TANGO1,UNQ6077
Fluorescent Reporter Null
Mammalian Cell Selection Null
Fusion Tag 3xflag (C-Terminal)
Promoter CMV
Resistance Amplicin
ORF Nucleotide Sequence ATGGACTCAGTACCTGCCACTGTGCCTTCTATCGCCGCTACCCCGGGGGACCCGGAACTTGTGGGACCCTTGTCTGTGCTCTACGCAGCCTTCATAGCCAAGCTGCTGGAGCTAGTTGCTACATTGCCTGATGATGTTCAGCCTGGGCCTGATTTTTATGGACTGCCATGGAAACCTGTATTTATCACTGCCTTCTTGGGAATTGCTTCGTTTGCCATTTTCTTATGGAGAACTGTCCTTGTTGTGAAGGATAGAGTATATCAAGTCACGGAACAGCAAATTTCTGAGAAGTTGAAGACTATCATGAAAGAAAATACAGAACTTGTACAAAAATTGTCAAATTATGAACAGAAGATCAAGGAATCAAAGAAACATGTTCAGGAAACCAGGAAACAAAATATGATTCTCTCTGATGAAGCAATTAAATATAAGGATAAAATCAAGACACTTGAAAAAAATCAGGAAATTCTGGATGACACAGCTAAAAATCTTCGTGTTATGCTAGAATCTGAGAGAGAACAGAATGTCAAGAATCAGGACTTGATATCAGAAAACAAGAAATCTATAGAGAAGTTAAAGGATGTTATTTCAATGAATGCCTCAGAATTTTCAGAGGTTCAGATTGCACTTAATGAAGCTAAGCTTAGTGAAGAGAAGGTGAAGTCTGAATGCCATCGGGTTCAAGAAGAAAATGCTAGGCTTAAGAAGAAAAAAGAGCAGTTGCAGCAGGAAATCGAAGACTGGAGTAAATTACATGCTGAGCTCAGTGAGCAAATCAAATCATTTGAGAAGTCTCAGAAAGATTTGGAAGTAGCTCTTACTCACAAGGATGATAATATTAATGCTTTGACTAACTGCATTACACAGTTGAATCTGTTAGAGTGTGAATCTGAATCTGAGGGTCAAAATAAAGGTGGAAATGATTCAGATGAATTAGCAAATGGAGAAGTGGGAGGTGACCGGAATGAGAAGATGAAAAATCAAATTAAGCAGATGATGGATGTCTCTCGGACACAGACTGCAATATCGGTAGTTGAAGAGGATCTAAAGCTTTTACAGCTTAAGCTAAGAGCCTCCGTGTCCACTAAATGTAACCTGGAAGACCAGGTAAAGAAATTGGAAGATGACCGCAACTCACTACAAGCTGCCAAAGCTGGACTGGAAGATGAATGCAAAACCTTGAGGCAGAAAGTGGAGATTCTGAATGAGCTCTATCAGCAGAAGGAGATGGCTTTGCAAAAGAAACTGAGTCAAGAAGAGTATGAACGGCAAGAAAGAGAGCACAGGCTGTCAGCTGCAGATGAAAAGGCAGTTTCGGCTGCAGAGGAAGTAAAAACTTACAAGCGGAGAATTGAAGAAATGGAGGATGAATTACAGAAGACAGAGCGGTCATTTAAAAACCAGATCGCTACCCATGAGAAGAAAGCTCATGAAAACTGGCTCAAAGCTCGTGCTGCAGAAAGAGCTATAGCTGAAGAGAAAAGGGAAGCTGCCAATTTGAGACACAAATTATTAGAATTAACACAAAAGATGGCAATGCTGCAAGAAGAACCTGTGATTGTAAAACCAATGCCAGGAAAACCAAATACACAAAACCCTCCACGGAGAGGTCCTCTGAGCCAGAATGGCTCTTTTGGCCCATCCCCTGTGAGTGGTGGAGAATGCTCCCCTCCATTGACAGTGGAGCCACCCGTGAGACCTCTCTCTGCTACTCTCAATCGAAGAGATATGCCTAGAAGTGAATTTGGATCAGTGGACGGGCCTCTACCTCATCCTCGATGGTCAGCTGAGGCATCTGGGAAACCCTCTCCTTCTGATCCAGGATCTGGTACAGCTACCATGATGAACAGCAGCTCAAGAGGCTCTTCCCCTACCAGGGTACTCGATGAAGGCAAGGTTAATATGGCTCCAAAAGGGCCCCCTCCTTTCCCAGGAGTCCCTCTCATGAGCACCCCCATGGGAGGCCCTGTACCACCACCCATTCGATATGGACCACCACCTCAGCTCTGCGGACCTTTTGGGCCTCGGCCACTTCCTCCACCCTTTGGCCCTGGTATGCGTCCACCACTAGGCTTAAGAGAATTTGCACCAGGCGTTCCACCAGGAAGACGGGACCTGCCTCTCCACCCTCGGGGATTTTTACCTGGACACGCACCATTTAGACCTTTAGGTTCACTTGGCCCAAGAGAGTACTTTATTCCTGGTACCCGATTACCACCCCCAACCCATGGTCCCCAGGAATACCCACCACCACCTGCTGTAAGAGACTTACTGCCGTCAGGCTCTAGAGATGAGCCTCCACCTGCCTCTCAGAGCACTAGCCAGGACTGTTCACAGGCTTTAAAACAGAGCCCATAA
ORF Protein Sequence MDSVPATVPSIAATPGDPELVGPLSVLYAAFIAKLLELVATLPDDVQPGPDFYGLPWKPVFITAFLGIASFAIFLWRTVLVVKDRVYQVTEQQISEKLKTIMKENTELVQKLSNYEQKIKESKKHVQETRKQNMILSDEAIKYKDKIKTLEKNQEILDDTAKNLRVMLESEREQNVKNQDLISENKKSIEKLKDVISMNASEFSEVQIALNEAKLSEEKVKSECHRVQEENARLKKKKEQLQQEIEDWSKLHAELSEQIKSFEKSQKDLEVALTHKDDNINALTNCITQLNLLECESESEGQNKGGNDSDELANGEVGGDRNEKMKNQIKQMMDVSRTQTAISVVEEDLKLLQLKLRASVSTKCNLEDQVKKLEDDRNSLQAAKAGLEDECKTLRQKVEILNELYQQKEMALQKKLSQEEYERQEREHRLSAADEKAVSAAEEVKTYKRRIEEMEDELQKTERSFKNQIATHEKKAHENWLKARAAERAIAEEKREAANLRHKLLELTQKMAMLQEEPVIVKPMPGKPNTQNPPRRGPLSQNGSFGPSPVSGGECSPPLTVEPPVRPLSATLNRRDMPRSEFGSVDGPLPHPRWSAEASGKPSPSDPGSGTATMMNSSSRGSSPTRVLDEGKVNMAPKGPPPFPGVPLMSTPMGGPVPPPIRYGPPPQLCGPFGPRPLPPPFGPGMRPPLGLREFAPGVPPGRRDLPLHPRGFLPGHAPFRPLGSLGPREYFIPGTRLPPPTHGPQEYPPPPAVRDLLPSGSRDEPPPASQSTSQDCSQALKQSP

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    Target Antibody GM-Tg-g-SE0348-Ab Anti-TGO1/ MIA3/ ARNT functional antibody
    Target Antigen GM-Tg-g-SE0348-Ag MIA3 protein
    ORF Viral Vector pGMAD000114 Human MIA3 Adenovirus plasmid
    ORF Viral Vector vGMAD000114 Human MIA3 Adenovirus particle


    Target information

    Target ID GM-SE0348
    Target Name MIA3
    Gene Group Identifier
    （Target Gene ID in Homo species)         		375056
    Gene ID 100053461 (Equus caballus), 100855882 (Canis lupus familiaris), 101097539 (Felis catus), 338366 (Mus musculus)
    375056 (Homo sapiens), 509133 (Bos taurus), 683007 (Rattus norvegicus), 704405 (Macaca mulatta)
    Gene Symbols & Synonyms MIA3,Mia3,Tango,Gm1525,TANGO1,9130229H14Rik,A930039G15Rik,B230399H06Rik,ARNT,D320,ODCD2,TANGO,UNQ6077
    Target Alternative Names 9130229H14Rik,A930039G15Rik,ARNT,B230399H06Rik,C219-reactive peptide,D320,Gm1525,MIA3,Melanoma inhibitory activity protein 3,Mia3,ODCD2,TANGO,TANGO1,Tango,Transport and Golgi organization protein 1 homolog,UNQ6077
    Uniprot Accession Q0VC16,Q5JRA6,Q8BI84
    Additional SwissProt Accessions: Q8BI84,Q5JRA6,Q0VC16
    Uniprot Entry Name
    Protein Sub-location Secreted Protein/Potential Cytokines
    Category
    Disease
    Disease from KEGG
    Gene Ensembl ENSECAG00000035616, ENSCAFG00845030361, ENSMUSG00000056050, ENSG00000154305, ENSBTAG00000018824, ENSMMUG00000001021
    Target Classification


    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.